Demographics of all patients | Control group (N=273) | Intervention group (N=266) | p Value |
---|---|---|---|
Gender | 125 (46%) male 148 (54%) female | 156 (59%) male 110 (41%) female | 0.003 |
Mean age (range) | 23 (15–61) | 25 (15–66) | 0.0065 |
Ethnicity | |||
Black | 153 (56%) | 116 (44%) | 0.04 |
White | 77 (28%) | 88 (33%) | |
Other | 43 (16%) | 62 (23%) | |
Reattendance rates by initial risk category | Control group (95% CI) | Intervention group (95% CI) | |
Chlamydia | 43/121 (36%) (28 to 44%) | 64/123 (52%) (43 to 61%} | 0.03 |
Gonorrhoea | 4/21 (19%) (7 to 41%) | 41/64 (64%) (52 to 75%) | 0.0003 |
Women receiving emergency contraception | 27/60 (45%) (33 to 58%) | 9/18 (50%) (29 to 71%) | n.s |
MSM | 3/18(16%) (5 to 40%) | 26/45 (58%) (43 to 71%) | 0.006 |
Other risks | 12/54 (22%) (13 to 35%) | 9/16 (56%) (33 to 77%) | n.s |
Total reattendance | 90/273 (33%) (28 to 39%) | 149/266 (56%) (50 to 62%) | 0.0001 |
Reattendance rates by ethnicity, age and gender | |||
Reattendance rate White | 21/77 (27%) (19 to 38%) | 44/87 (51%) (40 to 61%) | 0.01 |
Reattendance rate Black | 56/153 (37%) (29 to 44%) | 64/116 (55%) (46 to 64%) | 0.003 |
Reattendance rate Other | 12/43 (28%) (16 to 43%) | 41/63(65%) (53 to 76%) | 0.001 |
Reattendance rate 15–25-year-old | 68/179 (38%) (31 to 45%) | 78/136 (57%) (49 to 65%) | 0.0009 |
Reattendance rate >25–year-old | 21/94 (22%) (15 to 32%) | 71/130 (55%) (46 to 63%) | 0.0001 |
Reattendance rate men | 26/125 (21%) (15 to 29%) | 79/156 (51%) (43 to 58%) | 0.0001 |
Reattendance rate women | 63/148 (43%) (35 to 51%) | 70/110 (64%) (54 to 72%) | 0.002 |
STI rates in reattending patients | |||
STIs diagnosed in reattending patients | 13/90 (14%) (9 to 23%) | 26/149 (17%) (12 to 24%) | n.s |
STIs diagnosed in Chlamydia group at reattendance | 9/43 (21%) (11 to 35%) | 8/64 (13%) (6 to 23%) | n.s |
STIs diagnosed in Gonorrhoea group at reattendance | 0/4 (0%) | 12/41 (29%) (18 to 45%) | n.s |
MSM, men who have sex with men; STIs, sexual transmitted infections.